Li Xi-Kun, Gao Xiao-Li, Li Yan, Xu Hong, Fan Chen-Lu
Division of Immunization Program, Harbin Center for Disease Control and Prevention, Harbin 150056, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2019 Mar;21(3):203-207. doi: 10.7499/j.issn.1008-8830.2019.03.003.
To investigate the level of IgG antibody to varicella in the healthy population aged 1-19 years in Harbin, China.
Random sampling was performed to select 1 203 healthy individuals aged 1-19 years in Harbin. According to age, they were divided into ≥1 years group (n=240), ≥4 years group (n=396), ≥7 years group (n=364) and 14-19 years group (n=203). Enzyme-linked immunosorbent assay was used to measure the concentration of varicella-zoster virus (VZV)-IgG antibody in serum, and a concentration of VZV-IgG antibody of ≥100 mIU/mL was considered positive, suggesting that the subject had the ability to resist VZV infection.
The overall positive rate of VZV-IgG antibody was 71.49% (860/1 203), and the concentration of VZV-IgG antibody was 447±17 mIU/mL. The concentration of VZV-IgG antibody tended to increase with age (P<0.05). The positive rate of VZV-IgG antibody in the urban population was significantly higher than that in the rural population (P<0.05). There was significant difference in the positive rate of VZV-IgG antibody between the populations with different doses of varicella vaccination (P<0.05), and the population with 2 doses of vaccination had the highest positive rate of VZV-IgG antibody. There was a significant difference in the concentration of VZV-IgG antibody between the populations with different medical histories (P<0.05), and the population with a past history of varicella had the highest concentration.
Among the healthy population aged 1-19 years in Harbin, there is a significant difference in the level of VZV-IgG antibody between the urban and rural populations, as well as between different age groups. Varicella vaccination should be strengthened in areas with a low vaccination rate and the population aged <14 years.
研究中国哈尔滨1 - 19岁健康人群中水痘IgG抗体水平。
随机抽样选取哈尔滨1203名1 - 19岁健康个体。按年龄分为≥1岁组(n = 240)、≥4岁组(n = 396)、≥7岁组(n = 364)和14 - 19岁组(n = 203)。采用酶联免疫吸附测定法检测血清中水痘 - 带状疱疹病毒(VZV)-IgG抗体浓度,VZV - IgG抗体浓度≥100 mIU/mL为阳性,提示受试者有抵抗VZV感染的能力。
VZV - IgG抗体总体阳性率为71.49%(860/1203),VZV - IgG抗体浓度为447±17 mIU/mL。VZV - IgG抗体浓度随年龄增长呈上升趋势(P<0.05)。城市人群VZV - IgG抗体阳性率显著高于农村人群(P<0.05)。不同水痘疫苗接种剂量人群的VZV - IgG抗体阳性率存在显著差异(P<0.05),接种2剂疫苗人群的VZV - IgG抗体阳性率最高。不同病史人群的VZV - IgG抗体浓度存在显著差异(P<0.05),有过水痘病史人群的VZV - IgG抗体浓度最高。
在哈尔滨1 - 19岁健康人群中,城市和农村人群以及不同年龄组之间VZV - IgG抗体水平存在显著差异。应在疫苗接种率低的地区和<14岁人群中加强水痘疫苗接种。